GoodRx Holdings, Inc.
GDRX
$4.43
-$0.045-1.01%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.99% | 8.50% | 5.76% | 7.55% | 6.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.99% | 8.50% | 5.76% | 7.55% | 6.81% |
| Cost of Revenue | 14.27% | -37.59% | -27.35% | -25.32% | -38.54% |
| Gross Profit | 0.22% | 13.85% | 8.89% | 10.83% | 11.53% |
| SG&A Expenses | -9.91% | -9.02% | 12.44% | 9.18% | 43.74% |
| Depreciation & Amortization | 717.59% | -46.90% | 5.39% | 6.71% | -119.91% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.06% | -19.90% | 5.46% | 2.79% | -4.62% |
| Operating Income | -34.40% | 153.24% | 8.58% | 80.31% | 48.63% |
| Income Before Tax | 146.31% | 117.41% | -3.50% | -91.85% | -419.18% |
| Income Tax Expenses | 278.36% | 151.16% | 110.60% | -81.09% | 144.50% |
| Earnings from Continuing Operations | 126.05% | 110.30% | -88.61% | 69.33% | -1,211.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 126.05% | 110.30% | -88.61% | 69.33% | -1,211.82% |
| EBIT | -34.40% | 153.24% | 8.58% | 80.31% | 48.63% |
| EBITDA | -33.55% | 815.08% | 7.09% | 38.42% | 14.45% |
| EPS Basic | 127.57% | 111.17% | -87.52% | 67.50% | -1,237.50% |
| Normalized Basic EPS | -35.96% | 125.04% | 5.46% | 159.76% | 61.75% |
| EPS Diluted | 127.57% | 110.74% | -87.29% | 67.50% | -575.79% |
| Normalized Diluted EPS | -36.21% | 124.44% | 3.85% | 159.76% | 61.75% |
| Average Basic Shares Outstanding | -5.37% | -8.17% | -8.73% | -5.43% | -2.05% |
| Average Diluted Shares Outstanding | -4.88% | -6.03% | -7.14% | -5.43% | -2.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
